-- 根據彭博新聞週五援引知情人士報道，由新加坡主權財富基金GIC支持的電動汽車電池製造商遠景能源（Envision AESC）正考慮在香港進行首次公開募股（IPO），預計募資額在10億至20億美元之間。 報道稱，該公司正與銀行就潛在的股票發行進行磋商，最快可能在今年進行。 據悉，相關討論仍在進行中，包括發行規模和時間在內的細節可能會有所變動。 遠景能源在美國、英國、法國、西班牙、中國和日本均設有生產基地，並為全球主要汽車製造商供應電池。 （市場動態新聞來自與全球市場專業人士的對話。我們認為這些資訊來自可靠來源，但可能包含傳聞和猜測。我們不保證其準確性。）
Related Articles
Asia
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
$ASX:NAB
Asia
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
$ASX:CUV
Asia
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.
$ASX:XRF